+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


PharmAust Ltd (PAA) - Financial and Strategic SWOT Analysis Review

  • ID: 4282122
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel (MPL) is a small molecule that has been developed to treat parasite infections in food chain animals. MPL is an oral aminoacetonitrile (AAD) compound that modulates the mTOR pathway. The company’s product finds application in the treatment of multiple human indications including breast cancer, renal cell carcinoma, mantle cell lymphoma and pancreatic neuroendocrine tumours, Alzheimer’s, Parkinson’s and various ageing disorders. PharmAust is headquartered in Bentley, Western Australia, Australia.

PharmAust Ltd Key Recent Developments

Jan 31, 2018: PharmAust Appendix 4C and Shareholders Update (Q2, 2018 FY)
Jan 18, 2018: Epichem Awarded One Year Contract Extension from DNDi
Dec 18, 2017: International Vet Cancer Specialist Joins PharmAust Veterinary Advisory Board
Nov 29, 2017: PharmAust Launches New Corporate Website
Nov 16, 2017: PharmAust secures patent in US for new portfolio of anti-cancer drugs

This comprehensive SWOT profile of PharmAust Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PharmAust Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • PharmAust Ltd - Key Information
  • PharmAust Ltd - Overview
  • PharmAust Ltd - Key Employees
  • PharmAust Ltd - Key Employee Biographies
  • PharmAust Ltd - Key Operational Heads
  • PharmAust Ltd - Major Products and Services
  • PharmAust Ltd - History
  • PharmAust Ltd - Company Statement
  • PharmAust Ltd - Locations And Subsidiaries
  • PharmAust Ltd - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • PharmAust Ltd - Business Description
  • PharmAust Ltd - Corporate Strategy
  • PharmAust Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • PharmAust Ltd - Strengths
  • PharmAust Ltd - Weaknesses
  • PharmAust Ltd - Opportunities
  • PharmAust Ltd - Threats
  • PharmAust Ltd - Key Competitors
Section 3 - Company Financial Performance Charts
  • PharmAust Ltd - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • PharmAust Ltd, Key Information
  • PharmAust Ltd, Key Ratios
  • PharmAust Ltd, Share Data
  • PharmAust Ltd, Major Products and Services
  • PharmAust Ltd, History
  • PharmAust Ltd, Key Employees
  • PharmAust Ltd, Key Employee Biographies
  • PharmAust Ltd, Key Operational Heads
  • PharmAust Ltd, Other Locations
  • PharmAust Ltd, Subsidiaries
  • PharmAust Ltd, Key Manufacturing facilities
  • PharmAust Ltd, Key Competitors
  • PharmAust Ltd, SWOT Analysis
  • PharmAust Ltd, Ratios based on current share price
  • PharmAust Ltd, Annual Ratios
  • PharmAust Ltd, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PharmAust Ltd, Performance Chart
  • PharmAust Ltd, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3